Hostname: page-component-7c8c6479df-8mjnm Total loading time: 0 Render date: 2024-03-28T19:55:03.098Z Has data issue: false hasContentIssue false

Comparative use of muscle relaxants and their reversal in three European countries: a survey in France, Germany and Great Britain

Published online by Cambridge University Press:  04 August 2006

C. Osmer
Affiliation:
Department of Anaesthetics and Surgical Intensive Care, Justus-Liebig-University, Giessen, Department of Psychology, Philipps-University, Marburg, Germany
C. Vogele
Affiliation:
Department of Anaesthetics and Surgical Intensive Care, Justus-Liebig-University, Giessen, Department of Psychology, Philipps-University, Marburg, Germany
B. Zickmann
Affiliation:
Department of Anaesthetics and Surgical Intensive Care, Justus-Liebig-University, Giessen, Department of Psychology, Philipps-University, Marburg, Germany
G. Hempelmann
Affiliation:
Department of Anaesthetics and Surgical Intensive Care, Justus-Liebig-University, Giessen, Department of Psychology, Philipps-University, Marburg, Germany
Get access

Abstract

A survey was conducted among British, French and German anaesthetists to evaluate possible national differences in the peri-operative use of muscle relaxants and their reversal agents. The same non-depolarizing relaxants are used in all three countries, with the exception of d-tubocurarine, which is only available in Great Britain, and alcuronium which is mainly used in Germany. The French anaesthetists seem to use significantly less succinylcholine than their peers in Great Britain or Germany for both elective and emergency intubation. Monitoring of neuromuscular blockade still relies mainly on ‘clinical judgement’. Reversal of non-depolarizing muscle relaxants is performed routinely in Great Britain, while a substantial number of French anaesthetists avoid the use of a reversal. Dose regimes for neostigmine vary largely, with German anaesthetists administering the lowest, and British anaesthetists administering the highest doses. Side effects of reversal agents are reported by colleagues from all three countries in too high a percentage to justify uncritical administration of these drugs. In Germany there seems to be a noteworthy lack of recovery facilities.

Type
Original Article
Copyright
1996 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)